David Blair - Board Chair

David Blair has over 25 years of experience investing in and operating companies in the pharmacy services and ancillary markets. In 2023, David Blair, along with other leading industry professionals, founded LucyRx in response to the pressing demand for value-added pharmaceutical services companies. Serving as the Chief Executive Officer of LucyRx, David’s team aims to offer vital solutions for health plans grappling with substantial rises in complex, high-cost specialty drugs.

From 1998 through 2012, Mr. Blair served as chairman and chief executive officer of Catalyst Health Solutions Inc., a Fortune 500 company that was acquired by SXC Health Solutions in 2012 for $4.8 billion.

On average, Catalyst doubled in size every two years, earning a position on Fortune’s 100 Fastest-Growing Companies list five times and recognition as a Fortune 500 company in 2012. Catalyst was also the recipient of numerous prestigious healthcare and financial industry awards including Fortune’s “World’s Most Admired Companies”; the Washington Post 200, URAC Award for Best Practices in Health Care; e-Healthcare Leadership Awards; Interactive Media Awards for its drug pricing tools and three Pharmacy Benefit Management Institute Rx Benefit Innovation Awards.

Mr. Blair’s management skills and accomplishments resulted in numerous awards and recognition including Forbes America’s 15 Most Powerful CEOs under 40 (years of age). In addition to his philanthropic activities, Mr. Blair has remained active in the healthcare industry since the sale of Catalyst; his investments in private companies and board involvement include Gateway Health Partners, Comprehensive Clinical Solutions, HRGi, MedImpact, Medical Payments Exchange, and Expion Health, among others in the healthcare and pharmacy services spaces. Mr. Blair holds a B.A. in finance from Clemson University.